Molecular imaging of prostate cancer

Anne Marie Boustani, Darko Pucar, Lawrence Saperstein

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Prostate cancer is a common malignancy with various treatments from surveillance, surgery, radiation and chemotherapy. The institution of appropriate, effective treatment relies in part on accurate imaging. Molecular imaging techniques offer an opportunity for increased timely detection of prostate cancer, its recurrence, as well as metastatic disease. Advancements within the field of molecular imaging have been complex with some agents targeting receptors and others acting as metabolic intermediaries. In this article, we provide an overview of the most clinically relevant radiotracers to date based on a combination of the five States model and the National Comprehensive Cancer Network Guidelines.

Original languageEnglish (US)
Article number20170736
JournalBritish Journal of Radiology
Volume91
Issue number1084
DOIs
StatePublished - Jan 1 2018

Fingerprint

Molecular Imaging
Prostatic Neoplasms
Neoplasms
Guidelines
Radiation
Recurrence
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Boustani, A. M., Pucar, D., & Saperstein, L. (2018). Molecular imaging of prostate cancer. British Journal of Radiology, 91(1084), [20170736]. https://doi.org/10.1259/bjr.20170736

Molecular imaging of prostate cancer. / Boustani, Anne Marie; Pucar, Darko; Saperstein, Lawrence.

In: British Journal of Radiology, Vol. 91, No. 1084, 20170736, 01.01.2018.

Research output: Contribution to journalReview article

Boustani, AM, Pucar, D & Saperstein, L 2018, 'Molecular imaging of prostate cancer', British Journal of Radiology, vol. 91, no. 1084, 20170736. https://doi.org/10.1259/bjr.20170736
Boustani AM, Pucar D, Saperstein L. Molecular imaging of prostate cancer. British Journal of Radiology. 2018 Jan 1;91(1084). 20170736. https://doi.org/10.1259/bjr.20170736
Boustani, Anne Marie ; Pucar, Darko ; Saperstein, Lawrence. / Molecular imaging of prostate cancer. In: British Journal of Radiology. 2018 ; Vol. 91, No. 1084.
@article{c53bf4515fe94efdb45434b1aa9ef1fc,
title = "Molecular imaging of prostate cancer",
abstract = "Prostate cancer is a common malignancy with various treatments from surveillance, surgery, radiation and chemotherapy. The institution of appropriate, effective treatment relies in part on accurate imaging. Molecular imaging techniques offer an opportunity for increased timely detection of prostate cancer, its recurrence, as well as metastatic disease. Advancements within the field of molecular imaging have been complex with some agents targeting receptors and others acting as metabolic intermediaries. In this article, we provide an overview of the most clinically relevant radiotracers to date based on a combination of the five States model and the National Comprehensive Cancer Network Guidelines.",
author = "Boustani, {Anne Marie} and Darko Pucar and Lawrence Saperstein",
year = "2018",
month = "1",
day = "1",
doi = "10.1259/bjr.20170736",
language = "English (US)",
volume = "91",
journal = "British Journal of Radiology",
issn = "0007-1285",
publisher = "British Institute of Radiology",
number = "1084",

}

TY - JOUR

T1 - Molecular imaging of prostate cancer

AU - Boustani, Anne Marie

AU - Pucar, Darko

AU - Saperstein, Lawrence

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Prostate cancer is a common malignancy with various treatments from surveillance, surgery, radiation and chemotherapy. The institution of appropriate, effective treatment relies in part on accurate imaging. Molecular imaging techniques offer an opportunity for increased timely detection of prostate cancer, its recurrence, as well as metastatic disease. Advancements within the field of molecular imaging have been complex with some agents targeting receptors and others acting as metabolic intermediaries. In this article, we provide an overview of the most clinically relevant radiotracers to date based on a combination of the five States model and the National Comprehensive Cancer Network Guidelines.

AB - Prostate cancer is a common malignancy with various treatments from surveillance, surgery, radiation and chemotherapy. The institution of appropriate, effective treatment relies in part on accurate imaging. Molecular imaging techniques offer an opportunity for increased timely detection of prostate cancer, its recurrence, as well as metastatic disease. Advancements within the field of molecular imaging have been complex with some agents targeting receptors and others acting as metabolic intermediaries. In this article, we provide an overview of the most clinically relevant radiotracers to date based on a combination of the five States model and the National Comprehensive Cancer Network Guidelines.

UR - http://www.scopus.com/inward/record.url?scp=85044692114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044692114&partnerID=8YFLogxK

U2 - 10.1259/bjr.20170736

DO - 10.1259/bjr.20170736

M3 - Review article

C2 - 29243485

AN - SCOPUS:85044692114

VL - 91

JO - British Journal of Radiology

JF - British Journal of Radiology

SN - 0007-1285

IS - 1084

M1 - 20170736

ER -